Reflucalm: Clinical Study on Adult Gastroesophageal Reflux Disease (GERD) Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal conditions worldwide, affecting a large portion of the adult population. Symptoms such as heartburn, acid regurgitation, chest pain, and digestive discomfort can significantly impair quality of life. In this context, the medical device Reflucalm offers…
A natural alternative for a widespread condition Gastroesophageal reflux is a very common condition that affects millions of people worldwide, causing symptoms such as heartburn, acid regurgitation, bloating, and epigastric pain. Proton pump inhibitors are the most common treatment. However, using them for a long time can cause serious side effects. These side effects include…
Medical device with Hyaluronic Acid, Magnesium Alginate, and Myrrh: intense and lasting relief against gastroesophageal reflux Starting from 2025, we have officially registered our Class IIa medical device for the treatment of severe gastroesophageal reflux disease (GERD) with the Ministry of Health and Prevention of the United Arab Emirates (UAE). Severe GERD: a significant impact…
Extension of MDD Certificate for Our Medical Devices for the Treatment of Gastroesophageal Reflux Disease (GERD) Based on Alginates The MDR regulation, effective from May 2017 and applicable from May 2021, governs medical devices in Europe. Deadline extensions allow the marketing of devices compliant with the Medical Devices Directive (MDD) until December 31, 2027, for…
Gruppo FarmaImpresa completes the registration process for an oral emulsion for Gastroesophageal Reflux Disease Treatment With pride, we present our recent success in obtaining registration for a Class IIa medical device in Vietnam. This device, based on low molecular weight hyaluronic acid, sodium alginate, myrrh extract, and simethicone, is indicated for the treatment of gastroesophageal…